The pharmaceutical industry is pushing back against Governor Cuomo's prescription drug price control proposal, arguing that it would lead to cuts in research. And they are pointing the finger at insurance companies and companies known as pharmacy benefit managers for the high costs paid by patients. Peter Pitts is a former FDA Associate Commissioner for External Relations and is now President of the Center for Medicine in the Public Interest.
Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal
RECENT NEWS
We Can Fight Fraud Without Threatening Access to Care
When Washington fails to police its own programs, it’s hardworking Americans that pay the price. ... Read more
Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books
There is something almost too neat—too polished—about the way not-for-profit hospitals tell their financial story. It is... Read more
Modernizing North Carolina's Nonprofit Social Contract
Nonprofit hospitals occupy a uniquely privileged position in the American healthcare system. Their exemption from federal... Read more